INTERNATIONAL PATENT: BIOVENTURES, LLC FILES APPLICATION FOR "LEVERAGING CANCER-EVOLVED RESISTANCE MECHANISMS TO ENHANCE EZH2 ACTIVITY IN ADOPTIVE T CELLS"

GENEVA, Aug. 19 -- BIOVENTURES, LLC (4301 W. Markham St., #831Little Rock, AR 72205-7199) filed a patent application (PCT/US2025/014644) for "LEVERAGING CANCER-EVOLVED RESISTANCE MECHANISMS TO ENHANCE EZH2 ACTIVITY IN ADOPTIVE T CELLS" on Feb 05, 2025. With publication no. WO/2025/171047, the details related to the patent application was published on Aug 14, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): REED, Megan (c/o Bioventures, LLC4301 W. Markham St., #831Little Rock, AR 72205-7199), FIL, Daniel (c/o Bioventures, LLC4301 W. Markham St., #831Little Rock, AR 72205-7199), TACKETT, Alan (...